Medical Lung Cancer Journal is a peer-reviewed bimonthly journal publishing original articles describing different aspects of lung cancer medical and translation studies. Clinical Lung Cancer is devoted to research on lung cancer identification, diagnosis, prevention and treatment. The main focus is on recent scientific advances in all lung cancer-related areas. Different areas of interest include clinical research and mechanistic methods; tolerance and resistance to drugs; gene and antisense therapy; anatomy, markers and prognostic indicators; techniques for chemoprevention; multimodality therapy; and the combination of different approaches.
This Journal uses a double-blind peer review process and publishes high-quality articles in various categories, including original research articles, review articles, case reports, short communications, perspectives, editorials, editorial letters, etc. The members of the Journal Editorial Board conduct the peer review process and other esteemed experts provided that at least two or more independent reviewers approve the report, followed by the approval of the editors for final acceptance.
Published articles are freely accessible worldwide and can be accessed or downloaded without any permission but with the author’s copyright. Under the terms of the Creative Commons Attribution License papers are published.
Readers are always welcome to share their views / suggestions in the journal’s context.